%PDF-1.3
%
1 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 136>>stream
xA
0D9,E.V\t$1iM`{hQ
-$j(\hnW@/qZFos0/7&RJdɇ-ZR=6;w8("/O-t+
endstream
endobj
11 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2018-10-18T09:28:31-07:00
2018-10-06T02:34:03+05:30
application/pdf
JPM-2018-0149-ver9-Lima_3P 1458..1465
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:3e550665-7a7c-4fb2-a00c-368b8803875f
uuid:fdd03917-aee3-49df-a8a8-3ba5c06f4ae7
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
24 0 obj
<>stream
x+ |
endstream
endobj
25 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
26 0 obj
<>stream
x+ |
endstream
endobj
27 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
29 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(me)18.4(di)20.7(ca)12.8(ti)20.6(on)20.8(s)-479(w)0(e)18.8(r)0(e)-464.1(a)0(d)13.9(d)0(e)19.7(d)-473.4(fo)15.1(r)-473.4(t)0(h)20.7(e)-480.3(tr)20.7(ea)18.5(tm)19.5(en)19.7(t)-479.3(o)0(f)-468.7(c)0(a)18.5(n)0(c)19.7(e)0(r)-469.9(p)0(a)19.7(i)0(n)20.7(:)]TJ
0 -1.1174 TD
[(fe)14(nt)20.7(an)19.7(yl)-278.8(tr)15(an)19.7(sd)21(er)19.7(ma)18.4(l)-295(\()0(T)19.7(D)0(\))-279.5(p)0(a)19.7(t)0(c)13.8(h)-289.1(an)19.7(d)-294.8(m)0(e)18.4(t)0(h)20.7(a)0(d)19.7(o)0(n)20.8(e)-296(\(t)20.7(ab)19.7(le)19.6(t,)-281.1(or)20.9(al)19.5(,)]TJ
0 -1.1116 TD
-.0189 Tc
[(a)-18.9(n).8(d)-290.7(c)-18.9(on)-18.9(ce)-18.9(nt)-18.9(ra)-18.9(te)-18.9(\).)]TJ
7.3823 0 0 6.5614 126.5952 707.5841 Tm
0 Tc
(5)Tj
9.843 0 0 9.843 69.7323 692.277 Tm
[(Given)-330.2(that)-328.4(opioids)-330.3(are)-328.1(internationally)-331.8(controlled)-330.5(medica-)]TJ
-1.0137 -1.1116 TD
[(tions)-230.2(under)-225.5(the)-223.5(Single)-226.7(Convention)-232.3(of)-221(Narcotic)-232.3(Drugs)-225(\(hereon)]TJ
0 -1.1174 TD
[(referred)-311.7(to)-301.8(as)-308.4()50.8(Single)-302.7(Convention)43(\),)]TJ
7.3823 0 0 6.5614 208.0629 674.7021 Tm
(6)Tj
9.843 0 0 9.843 214.7527 670.3369 Tm
[(to)-301.8(procure)-309.5(the)-304.1(opioid)]TJ
-15.747 -1.1116 TD
[(medications,)-222.1(the)-217.7(corresponding)-223.9(national)-218.9(authorities)-222.1(must)-212.9(buy)]TJ
T*
[(from)-310.8(internationally)-314.5(licensed)-311.9(and)-309.7(authorized)-314.2(vendor\(s\).)-313.7(The)]TJ
0 -1.1174 TD
[(tendering,)-269.3(procurement,)-273.8(licensing,)-269.3(and)-263.7(exchange)-272.7(of)-267.1(goods)-264.5(at)]TJ
0 -1.1116 TD
[(the)-436.6(international)-438.9(level)-440.1(is)-434.1(monitored)-438.8(and)-436.4(controlled)-434.2(by)-434.2(the)]TJ
T*
[(International)-294.7(Narcotics)-296.5(Control)-291.2(Board)-295.7(\(INCB\),)-295.1(as)-291.2(part)-287.9(of)-290.2(its)]TJ
0 -1.1174 TD
[(mandate)-260.2(in)-255.8(the)-258(Single)-255.5(Convention.)-258.8(Controlled)-261.2(medicines)-256.6(are)]TJ
0 -1.1116 TD
[(sold)-292.3(in)-296.1(the)-292.6(international)-294.9(market)-292.5(by)-290.2(wholesalers)-298.5(and)-292.4(proprie-)]TJ
T*
[(tors)-217.4(of)-209.5(medications)-218.6(\(i.e.,)-216.4(Pharmaceutical)-219.7(companies\),)-214.9(and)-211.8(not)]TJ
T*
[(for)-383.4(prot)-379.8(entities)-380.1(\()16.2(f)16.2(o)0(r)-353.5(c)15(a)15(s)16.4(e)15(s)-363.8(of)-347.7(hu)26.6(m)15(a)15(n)16.2(i)16.1(t)0(a)25.3(r)16.2(i)16.1(a)15(n)-364(e)15(m)15(e)0(r)25.5(g)16.2(e)15(n)16.2(c)15(i)0(e)25.3(s)-363.8(i)16(n)]TJ
0 -1.1174 TD
-.0157 Tc
[(c)-15.7(o)9.7(untr)-15.7(i)10.8(es)-316.1(wit)-15.7(h)-306(limit)-15.7(e)9.6(d)-316.3(res)-15.7(o)11.1(urce)-15.7(s)9.9(\).)-318.6(Count)-15.7(r)10.8(i).4(es)-316.1(c)-15.7(a)8.6(n)-316.3(buy)-316.3(r)-15.7(a)9.8(w)-317.2(ma-)]TJ
0 -1.1116 TD
[(t)-15.8(e)9.5(rial)-241.7(for)-241.5(comp)-15.8(o)10.8(unde)-15.8(d)-226.5(p).4(r)-15.8(e)9.7(parat)-15.8(i)10.5(ons)-241.3(or)-241.5(for)-241.5(loca)-15.8(l)-226.6(man)-15.8(u)10.8(f).4(actu)-15.8(r)10.8(ing,)]TJ
T*
-.0159 Tc
[(a)-15.9(n)9.5(d/or)-385.6(b)-15.9(u)10.7(y)-385.6().4(nis)-15.9(h)10.9(ed)-385.6(pro)-15.9(d)10.7(u).3(cts)-15.9(,)-371.6(inc)-15.9(l)9.4(udin)-15.9(g)-375.2(brand)-15.9(e)9.5(d)-385.6(and)-385.6(g).3(ene)-15.9(r)9.6(ic)]TJ
0 -1.1174 TD
0 Tc
[(on)26.6(e)15(s)16.4(.)]TJ
1.0137 -1.1116 TD
[(In)-198(2014,)-192.2(the)-200.4(World)-197.9(Health)-200.1(Assembly)-196.1(unanimously)-198.9(adopted)]TJ
-1.0137 -1.1116 TD
[(a)-428.5(Palliative)-429.7(Care)-428.2(Resolution,)-431.5(which)-422.4(urges)-426.9(government)-8.9(s)-421.4(t)0(o)]TJ
0 -1.1174 TD
[(take)-306.4(the)-298.3(steps)-300.2(needed)-303.8(to)-296.1(ensure)-302.5(access)-304.6(to)-301.8(PC)-296.8(services)-305.8(to)-296.1(pa-)]TJ
0 -1.1116 TD
[(tients)-353.5(in)-347.9(need,)-344.2(including)-351.3(safe)-352.1(and)-344.3(effective)-354.6(access)-350.7(to)-347.9(medi-)]TJ
T*
[(cines)-232.4(for)-227.9(the)-229.2(treatment)-233.9(of)-226.8(pain)-230.3(and)-229.1(palliative)-228.3(care.)]TJ
7.3823 0 0 6.5614 254.381 477.4676 Tm
(7)Tj
9.843 0 0 9.843 260.3338 473.1022 Tm
(However,)Tj
-20.3778 -1.1174 TD
[(the)-206.2(vast)-201.3(majority)-201.6(of)-198(patients)-207.2(with)-201.4(legitimate)-200.7(medical)-202.8(needs)-203.5(do)]TJ
0 -1.1116 TD
[(not)-274.1(have)-271.7(adequate)-278.5(access)-275.8(to)-273(opioids)-272.7(for)-273.9(pain)-270.6(relief)-274.1(and)-275.2(other)]TJ
T*
(symptoms.)Tj
7.3823 0 0 6.5614 102.7275 444.5857 Tm
(8,9)Tj
9.843 0 0 9.843 69.7323 429.2786 Tm
[(Access)-425.3(to)-417(opioids)-416.7(is)-416.8(limited)-419.6(due)-419.2(to)-417(several)-425.8(reasons,)-416.2(in-)]TJ
-1.0137 -1.1174 TD
[(cluding)-251(restrictive)-252(drug)-252(control)-251(laws)-248.3(and)-252.1(regulations,)-248.4(limited)]TJ
0 -1.1116 TD
[(education)-353.5(of)-347.7(health)-349(professionals,)-353.8(and)-350(high)-344.4(prices.)]TJ
7.3823 0 0 6.5614 263.4519 411.7038 Tm
(10,11)Tj
9.843 0 0 9.843 283.5212 407.3385 Tm
(The)Tj
-22.7336 -1.1116 TD
[(use)-286.5(of)-284.4(opioid)-289.1(medications)-287.7(in)-284.6(low-)-287.6(and)-286.7(middle-income)-291.3(coun-)]TJ
0 -1.1174 TD
[(tries)-283.2(is)-278.6(particularly)-282.1(and)-280.9(signicantly)-280.7(affected)-284.2(by)-278.7(cost.)]TJ
7.3823 0 0 6.5614 271.2755 389.7637 Tm
[(12,)-9.4(13)]TJ
9.843 0 0 9.843 290.6645 385.3983 Tm
(In)Tj
-23.4593 -1.1116 TD
[(previous)-274.8(studies,)-277.1(the)-269.5(dispensing)-277(price)-272.9(of)-272.9(opioids)-272.7(in)-273(low-)-270.3(and)]TJ
T*
[(middle-income)-452.6(countries)-444.3(have)-444.5(been)-444.5(reported)-448.9(to)-440.1(be)-446.9(higher)]TJ
0 -1.1174 TD
[(than)-345.5(in)-342.1(high-income)-344.2(countries.)-349.8(as)-343(well)-346.5(as)-343(higher)-341.9(in)-342.1(smaller)]TJ
0 -1.1116 TD
[(towns)-282.8(and)-280.9(rural)-283.2(areas)-285.2(than)-282.2(in)-278.8(large)-284.4(urban)-277.3(areas.)]TJ
7.3823 0 0 6.5614 248.2582 345.9401 Tm
(14)Tj
9.843 0 0 9.843 69.7323 330.633 Tm
[(In)-457.2(2012,)-457.1(the)-459.6(International)-467.5(Association)-458.8(for)-458.3(Hospice)-460.1(and)]TJ
-1.0137 -1.1116 TD
[(Palliative)-291.5(Care)-290(\(IAHPC\))-286.7(developed)-290(and)-286.7(implemented)-289.2(a)-284.5(pro-)]TJ
0 -1.1174 TD
[(ject)-254.7(called)-258(Opioid)-249.6(Price)-255.4(Watch)-252.1(\(OPW\))-256.1(to)-250(collect,)-256.9(report,)-247.4(and)]TJ
0 -1.1116 TD
[(monitor)-285.6(the)-286.8(availability,)-291.6(dispensing)-288.5(prices,)-283(and)-286.7(affordability)]TJ
T*
[(of)-480.2(5)-484.9(opioids)-480.1(\(fentanyl,)-482.4(hydromorphone,)-486.6(methadone,)-484.7(mor-)]TJ
0 -1.1174 TD
[(phine,)-240.6(and)-240.6(oxycodone\))-237.9(in)-238.5(13)-238.3(formulations.)-243.8(The)-241.8(OPW)-236.7(project)]TJ
0 -1.1116 TD
[(is)-255.6(a)-261.4(component)-255.5(of)-255.6(the)-258(agreement)-257.8(betwe)-8.8(en)-251(IAHPC)-261.5(and)-257.9(WHO)]TJ
T*
[(as)-285.4(an)-279.8(NGO)-282.4(in)-278.8(formal)-285.5(relations)-283.1(with)-282(WHO.)]TJ
1.0137 -1.1174 TD
[(In)-290.1(the)-286.8(OPW)-288.5(study,)-291.1(participants)-293.5(were)-289.8(asked)-289.9(to)-290.3(provide)-285.4(the)]TJ
-1.0137 -1.1116 TD
[(lowest)-198.8(dispensing)-190.6(price)-198(of)-192.2(the)-194.7(smallest)-190.9(selling)-199.1(unit)-189(and)-194.5(lowest)]TJ
T*
[(strength)-361.3(of)-353.5(ve)-355.6(opioids)-353.4(in)-353.7(13)-353.5(formulations)-355.6(from)-356.9(a)-353.6(licensed)]TJ
0 -1.1174 TD
[(pharmacy)-399.4(located)-397.4(closest)-395.8(to)-394(a)-393.9(public)-393.9(facility)-397.5(that)-391.7(provides)]TJ
0 -1.1116 TD
[(diagnosis/treatment)-292.1(for)-279.7(life-threatening)-287.8(conditions.)]TJ
1.0137 -1.1116 TD
[(The)-345.5(price)-342(for)-343.1(a)-342.1(30-day)-347.6(treatment)-343.3(was)-345(calculated)-351.3(in)-342.1(three)]TJ
-1.0137 -1.1116 TD
[(steps:)-353.2(rst,)-347.4(the)-350.2(price)-353.5(per)-350(milligram)-348.1(\(mg\))-351.2(was)-350.7(calculated)-351.3(by)]TJ
0 -1.1174 TD
[(dividing)-412.4(the)-407.8(dispensing)-415.2(price)-411.1(of)-405.3(the)-413.5(package/bottle)-413.4(by)-405.4(the)]TJ
0 -1.1116 TD
[(total)-433.3(mg)-429.6(in)-422.8(each.)-431.8(Second,)-432.7(the)-430.8(resulting)-425.9(price)-434.1(per)-430.6(mg)-423.9(was)]TJ
T*
[(multiplied)-267.5(by)-261.4(the)-263.8(corresponding)-264.2(dened)-262.2(daily)-266.1(dose)-258.8(\(DDD\))]TJ
7.3823 0 0 6.5614 291.4582 148.7055 Tm
(15)Tj
9.843 0 0 9.843 59.7543 133.3417 Tm
[(for)-285.5(the)-281.1(daily)-283.4(price.)-282.1(Finally,)-283.2(the)-281.1(resulting)-287.7(price)-278.6(per)-286.7(milligram)]TJ
T*
[(per)-217.5(day)-217.6(was)-218.3(then)-218.8(multiplied)-215.6(by)-215.3(30.)-218.7(Table)-216.5(1)-220(includes)-218.6(the)-211.9(DDD)]TJ
T*
[(for)-285.5(each)-278.6(medication.)]TJ
1.0137 -1.1174 TD
[(The)-426.1(results)-434.9(from)-426(the)-425.1(rst)-430.4(phase)-428.1(of)-428.4(OPW)-426.7(indicated)-434.2(that)]TJ
-1.0137 -1.1116 TD
[(patients)-276.3(living)-271.9(in)-273(countries)-277.2(in)-273(lower)-272.6(economic)-272.9(groups)-277.1(had)-269.4(to)]TJ
T*
[(pay)-194.5(higher)-192.2(prices)-198.9(for)-193.3(opioids)-192.1(than)-190(those)-196.7(living)-191.3(in)-192.4(high-income)]TJ
0 -1.1174 TD
(countries.)Tj
7.3823 0 0 6.5614 98.4189 72 Tm
(16)Tj
9.843 0 0 9.843 109.1338 67.5779 Tm
[(Findings)-331.3(also)-333.8(indicated)-336.3(that)-334.1(regarding)-334.8(its)-337.4(inter-)]TJ
-5.0167 -1.1116 TD
[(national)-316.8(reference)-315.1(price,)-310.9(the)-309.9(median)-315.6(price)-313.2(of)-307.4(10)-169.2(mg)-308.7(of)-313.2(mor-)]TJ
25.5097 50.0346 TD
[(phine)-254.5(oral)-259.1(solid)-253.2(immediate)-263.9(release)-259.9(\(IR\))-258.8(was)-258.6(5.8)-253.3(times)-255.6(higher)]TJ
0 -1.1116 TD
[(in)-411.3(low-)-414.3(and)-413.4(middle-income)-412.3(countries)-415.5(than)-414.6(in)-411.3(high-income)]TJ
T*
(countries.)Tj
7.3823 0 0 6.5614 349.5117 531.6093 Tm
(17)Tj
9.843 0 0 9.843 320.8251 516.2455 Tm
[(In)-238.3(2016,)-238.2(the)-240.7(IAHPC)-244.2(developed)-243.9(and)-240.6(implement)-9.3(ed)-239.5(a)-238.4(second)]TJ
-1.0137 -1.1116 TD
[(round)-247.4(of)-249.8(OPW.)-251.6(Results)-251.7(from)-247.5(this)-252.1(round)-247.4(were)-249.5(consistent)-255.3(with)]TJ
T*
-.0159 Tc
[(t)-15.9(h)-15.9(e)-314.2(resul)-15.9(t)10.4(s)-293.3(o)-15.9(f)-283(t).2(he)-300.4(rs)-15.9(t)-283(and)-299.2(i).2(nd)-15.9(i)10.6(cate)-300.4(t).2(hat)-299.4(t).2(he)-300.4(availa)-15.9(b)9.5(i).2(lit)-15.9(y)-283.2(of)-299.2(opi-)]TJ
T*
-.0156 Tc
[(oids)-206.6(at)-201.1(t)-15.6(h)10.9(e)-202.2(p).6(h)-15.6(a)9.8(rmacy)-206.8(level)-206.9(i).5(s)-206.6(d).6(irect)-15.6(l)10.7(y)-201(co)-15.6(r)11(r).6(ela)-15.6(t)9.7(ed)-201(t)-15.6(o)-190.7(the)-207.9(c)-.6(ount)-15.6(r)10.9(ys)]TJ
0 -1.1174 TD
[(Gros)-15.6(s)-270.8(N)-.3(ation)-15.6(a)9.8(l)-281.8(Income)-282.8(a)-.6(n)-15.6(d)-265.5(t)-15.6(h)10.9(e)-277(h)-15.6(u)11(man)-281.6(devel)-15.6(o)10.9(pment)-281.8(i).4(n)-15.6(d)11(ex.)]TJ
7.3823 0 0 6.5614 538.3558 476.7873 Tm
-.0162 Tc
(18)Tj
9.843 0 0 9.843 320.8251 461.4802 Tm
0 Tc
[(For)-394.8(both)-396.2(reports)-400.4(of)-393.8(OPW)-403.7(studies,)-398.1(we)-395.9(found)-397.1(unexpected)]TJ
-1.0137 -1.1116 TD
[(favorable)-272.7(differences)-281.6(in)-273(the)-269.5(dispensing)-277(price)-272.9(of)-272.9(opioids)-272.7(with)]TJ
0 -1.1174 TD
[(complex)-339.7(delivery)-345.4(mechanisms)-345(compared)-341.8(to)-342.1(IR)-337.3(oral)-339.7(and)-344.3(in-)]TJ
0 -1.1116 TD
[(jectable)-227(morphine.)-222.1(In)-221(many)-219.9(instances,)-229.8(we)-223.1(found)-218.6(that)-224.7(fentanyl)]TJ
T*
[(TD)-177.1(pa)19.7(tc)13.8(he)19.7(s,)-177.1(su)21(st)15.1(ai)19.5(ne)19.7(d-)20.9(re)19.7(le)13.8(as)19.9(e)-186.6(\()0(S)15.3(R)0(\))-176(o)0(r)20.9(a)0(l)-182(m)0(o)19.6(r)0(p)20.9(h)0(i)14.9(n)0(e)19.7(,)-187.7(an)19.7(d)-191.2(S)0(R)-175.9(o)0(r)20.9(a)0(l)]TJ
0 -1.1174 TD
[(ox)20.8(yc)19.7(od)20.8(on)20.8(e)-273(w)0(e)18.8(r)0(e)-262.5(d)0(i)20.7(s)0(p)21(e)0(n)13.9(s)0(e)19.9(d)-271.8(at)-256.9(lo)15(we)18.8(r)-266(p)0(r)15.1(i)0(c)19.5(e)0(s)-262.4(t)0(h)20.7(a)0(n)-262.5(I)0(R)-256.6(m)0(o)19.6(r)0(p)15.1(h)0(i)20.7(n)0(e)19.7(.)]TJ
1.0137 -1.1116 TD
[(This)-253.2(is)-261.3(the)-258(third)-259.2(report)-255.5(of)-261.3(OPW.)-257.4(The)-259.1(purpose)-262.1(of)-255.6(this)-257.9(study)]TJ
-1.0137 -1.1116 TD
[(was)-281.6(to)-278.8(identify)-281(the)-281.1(extent)-279.9(to)-278.8(which)-284.1(SR)-279.5(and)-275.2(TD)-280.7(formulations)]TJ
T*
[(are)-241.7(dispensed)-248.1(at)-239.6(a)-244.2(lower)-243.8(price)-244.1(than)-241.8(generic)-247.4(IR)-239.3(morphine,)-245.1(and)]TJ
0 -1.1174 TD
[(the)-281.1(possible)-280.6(reasons)-286.1(to)-278.8(explain)-281(this)-280.9(observation.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 339.6472 Tm
(Methods)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 323.2062 Tm
[(We)-506.7(designed)-512.2(and)-505.6(implemented)-513.8(a)-509.1(cross-sectional)-516.3(study)]TJ
-1.0137 -1.1174 TD
[(during)-254.4(the)-252.3(months)-255.5(of)-255.6(February)-252.8(to)-255.7(June)-253(2017,)-255.5(which)-255.3(included)]TJ
0 -1.1116 TD
[(four)-280.8(steps:)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 310.8472 278.022 Tm
(Prices)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 261.6378 Tm
[(Using)-179.1(the)-188.9(data)-185.4(collected)-187.7(and)-183(the)-183.1(results)-187.3(from)-184.1(both)-183.1(phases)-187.1(of)]TJ
-1.0137 -1.1174 TD
[(the)-217.7(OPW,)-222.8(we)-223.1(identied)-219.8(the)-223.5(locations)-225.5(and)-217.6(the)-223.5(countries)-219.6(where)]TJ
0 -1.1116 TD
[(the)-442.3(reported)-448.9(dispensing)-444(price)-445.7(of)-445.7(IR)-446.7(oral)-443.4(and/or)-445.6(injectable)]TJ
T*
[(morphine)-351.1(was)-356.5(higher)-347.7(than)-357(at)-349.1(least)-353.5(one)-350(of)-353.5(the)-350.2(other)-352.4(opioids)]TJ
0 -1.1174 TD
[(with)-218.6(complex)-218.7(delivery)-218.7(formulations)-217.3(\(TD)-218.4(and)-217.6(SR\))-217.3(included)-218.8(in)]TJ
0 -1.1116 TD
[(the)-281.1(study:)]TJ
/F8 1 Tf
.91 -1.7222 TD
(-)Tj
/F5 1 Tf
1.054 0 TD
[(Fentanyl)-333.8([transdermal)-340.5(\(TD\))-334.7(patches])]TJ
/F8 1 Tf
-1.054 -1.1116 TD
(-)Tj
/F5 1 Tf
1.054 0 TD
[(Hydromorphone)-334.3([oral)-335(solid,)-337.3(SR])]TJ
/F8 1 Tf
-1.054 -1.1116 TD
(-)Tj
/F5 1 Tf
1.054 0 TD
[(Morphine)-333.5([oral)-335(solid,)-337.3(SR])]TJ
/F8 1 Tf
-1.054 -1.1174 TD
(-)Tj
/F5 1 Tf
1.054 0 TD
[(Oxycodone)-335.7(\(oral)-335(solid)-333.9(SR\))]TJ
-.9504 -1.7164 TD
[(In)-203.8(this)-200.3(study,)-204.7(we)-205.8(included)-207.2(only)-206.1(those)-202.4(locations)-208.3(in)-203.9(which)-209.3(we)]TJ
-1.0137 -1.1174 TD
[(observed)-212.5(higher)-215.2(dispensing)-207.9(price)-215.3(of)-209.5(IR)-216.3(morphine)-212.9(\(oral)-208.3(and/or)]TJ
0 -1.1116 TD
(injectable\).)Tj
/F9 1 Tf
8.9663 0 0 8.9663 310.8472 94.9039 Tm
[(Essential)-333.9(medicines)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 78.463 Tm
[(In)-342(a)-353.6(second)-348.6(step,)-348.8(from)-345.4(the)-350.2(list)-350.2(of)-347.7(18)-347.8(countries)-346.3(where)-354.3(we)]TJ
-1.0137 -1.1116 TD
[(observed)-212.5(higher)-215.2(dispensing)-207.9(price)-215.3(of)-209.5(IR)-216.3(morphine)-212.9(\(oral)-208.3(and/or)]TJ
T*
[(injectable\),)-446.9(we)-436.2(identied)-444.4(12)-439.9(that)-443.6(were)-439.5(classied)-445.1(either)-446.9(as)]TJ
ET
310.847 709.512 239.074 .22681 re
f
310.847 592.327 239.074 .28345 re
f
310.847 660.926 239.074 .28351 re
f
BT
/F7 1 Tf
9.845 0 0 9.845 316.8566 725.1588 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(1.)Tj
/F7 1 Tf
1.2496 0 TD
[(Amount)-338.1(Needed)-334.6(for)-332.2(a)]TJ
/F5 1 Tf
10.3769 0 TD
(30)Tj
/F7 1 Tf
.9962 0 TD
[(-Day)-338.4(Treatment)]TJ
-8.9257 -1.0135 TD
[(for)-338(Each)-334.4(Medication)]TJ
/F10 1 Tf
-7.3076 -4.8775 TD
(Medicationformulation)Tj
14.477 1.0135 TD
(DDD)Tj
.1325 -1.0135 TD
(\(mg\))Tj
5.9313 3.0348 TD
(30-day)Tj
-.5298 -1.0135 TD
(treatment)Tj
-.4319 -1.0077 TD
(\(DDD)Tj
/F8 1 Tf
2.6547 0 TD
()Tj
/F10 1 Tf
.7198 0 TD
(30\))Tj
-1.9637 -1.0135 TD
(\(mg\))Tj
/F5 1 Tf
-20.9899 -1.8946 TD
[(FentanylTD)-8821.2(1)]TJ
/F11 1 Tf
15.3292 0 TD
($)Tj
/F5 1 Tf
.6162 0 TD
5.4889 Tc
[(23)5488.9(6)]TJ
-15.9454 -1.0135 TD
0 Tc
[(Hydromorphoneoral)-6133.1(20)-5127.1(600)]TJ
T*
[(Hydromorphoneinjectable)-4277.3(4)-5131.9(120)]TJ
T*
[(Morphineoral)-8298.1(100)-4627.1(3000)]TJ
0 -1.0077 TD
[(Morphineinjectable)-6448.1(30)-5127.1(900)]TJ
0 -1.0135 TD
[(Oxycodoneoral)-8133.1(75)-4626.1(2250)]TJ
8.7511 0 0 8.7511 318.7841 580.5353 Tm
[(DDD,)-336.4(dened)-332.1(daily)-336.2(dose.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(OPIOID)-336.3(PRICE)-333.8(WATCH)-338(PROJECT)]TJ
52.4612 0 TD
(1459)Tj
ET
endstream
endobj
41 0 obj
<>stream
hlJ@$2GRZQ*m3m2
>DBz1&MO~0g0.n˳ ߵ|?zG,?:<|?}cg]d9瓱6JWjPÔ 29itN!ƶNQcTI" A*CDOp-aY-NĥIc.Sx&;);7{vVϧ+b\MbYq
{
endstream
endobj
44 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(middle)-262.7(\(upper)-261.1(and)-257.9(low\))-264.6(or)-255.6(low,)-261.2(based)-261.1(on)-261.4(their)-260.3(income)-263.7(levels)]TJ
0 -1.1174 TD
[(as)-325.7(per)-327(the)-327.1(World)-330.4(Bank.)]TJ
7.3823 0 0 6.5614 156.2456 718.5825 Tm
(19)Tj
9.843 0 0 9.843 166.8472 714.1605 Tm
[(One)-327.9(of)-330.5(the)-327.1(coauthors)-328.9(\(N.A.\))-324(con-)]TJ
-10.6497 -1.1116 TD
[(ducted)-204.9(an)-204.9(initial)-205.3(literature)-205(review)-211.5(and)-200.3(a)-203.8(search)-205.7(in)-203.9(the)-206.2(websites)]TJ
T*
[(of)-244.1(the)-240.7(Ministries)-243.6(of)-244.1(Health,)-243.9(the)-246.5(WHO)-243.5(website,)-244.8(and)-240.6(the)-240.7(WHO)]TJ
T*
[(Regional)-369.5(Ofces)-366.5(websites)-363.2(and)-367.3(obtained)-362.7(copies)-366(of)-365(their)-364(na-)]TJ
0 -1.1174 TD
[(tional)-468.9(lists)-460.5(of)-468.7(essential)-468.4(medicines,)-467.4(either)-464.2(by)-468.7(downloading)]TJ
0 -1.1116 TD
[(them)-306.4(directly)-311(from)-305.1(the)-309.9(Ministry)-309.4(of)-307.4(Health)-309.6(website)-304.7(or)-307.4(by)-307.5(re-)]TJ
T*
[(questing)-269.2(a)-267.2(copy)-264.8(from)-264.7(the)-269.5(Ministry)-269.1(of)-261.4(Health)-269.3(ofce.)-270.3(The)-264.8(lists)]TJ
0 -1.1174 TD
[(of)-215.3(essential)-226.5(medicines)-222(were)-220.7(analyzed)-220.9(by)-215.3(two)-217.4(coauthors)-219.5(\(N.A.)]TJ
0 -1.1116 TD
[(and)-304(L.D.L.\))-300.2(to)-301.8(answer)-303.3(two)-303.8(questions:)-305.9(\(1\))-297(Do)-302.6(they)-305.2(have)-300.5(opi-)]TJ
T*
[(oids)-447.8(included?)-445.6(If)-445.6(yes,)-445.4(\(2\))-446.7(Which)-446.8(ones?)-445.4(Those)-445.4(which)-445.4(had)]TJ
0 -1.1174 TD
[(opioids)-457(with)-454.8(complex)-460.7(delivery)-454.9(mechanisms)-460.2(\(SR)-459.2(and)-453.7(TD\))]TJ
0 -1.1116 TD
[(were)-284(included)-282.1(in)-278.8(this)-280.9(second)-285.2(analysis.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 62.022 570.614 Tm
[(Procurement)-335.3(process)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 554.1731 Tm
[(In)-307.4(a)-313.3(third)-311(step,)-308.4(we)-309.5(tried)-312.2(to)-307.6(nd)-314.2(information)-308.6(related)-316.7(to)-307.6(the)]TJ
-1.0137 -1.1174 TD
[(budget)-393.8(allocation)-400.9(for)-394.9(essential)-399.3(medicines)-394.8(\(in)-395.1(particular)-400.7(for)]TJ
0 -1.1116 TD
[(opioids\),)-547.9(any)-545.9(information)-550.5(on)-549.4(the)-546(process)-551(leading)-551.7(to)-543.7(the)]TJ
T*
[(identication)-266(and)-257.9(selection)-267(of)-261.4(medications)-264.7(subsidized)-260.9(by)-261.4(the)]TJ
0 -1.1174 TD
[(government)-319.9(programs,)-319.6(and)-315.5(any)-315.5(information)-314.3(on)-319(the)-315.6(procure-)]TJ
0 -1.1116 TD
[(ment)-185.5(and)-183(tendering)-179.5(proces)-8.7(s)-179.5(for)-181.8(medicines)-187.5(in)-180.9(the)-183.1(public)-180.8(sector.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 62.022 476.3337 Tm
[(Conrmation)-339.2(of)-330.2(information)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 459.8928 Tm
[(In)-192.2(a)-192.3(nal)-189.8(step,)-193.2(we)-194.3(contacted)-199.1(through)-192.1(e-mail)-194.7(the)-194.7(participants)]TJ
-1.0137 -1.1174 TD
[(of)-365(the)-361.7(previous)-367(two)-367.2(OPW)-363.4(studies)-365.8(and)-367.3(invited)-360.6(them)-369.8(to)-359.4(par-)]TJ
0 -1.1116 TD
[(ticipate)-272(as)-262.4(collaborators.)-274.8(Individuals)-266.9(who)-263.4(accepted,)-271.6(received)]TJ
T*
[(a)-203.8(letter)-210.9(that)-201.7(they)-207.3(could)-202.6(use)-205.9(to)-203.9(contact)-207.3(the)-206.2(corresponding)-212.4(ofce)]TJ
0 -1.1174 TD
[(in)-273(the)-275.3(Ministry)-269.1(of)-272.9(Health)-275(or)-272.9(Drug/Medicines)-280(Administration)]TJ
0 -1.1116 TD
[(Authority)-414.3(to)-405.5(inquire)-412.3(on)-411.1(the)-407.8(questi)-7.8(ons)-406.3(described)-416.5(in)-405.5(Step)-414.5(B)]TJ
T*
[(above.)-333.8(We)-328.2(also)-328(asked)-330.2(them)-335.2(to)-324.9(request)-332.5(the)-327.1(relevant)-335.1(national)]TJ
T*
[(authority)-305.2(permission)-301.2(to)-301.8(share)-301.3(their)-300.6(contact)-305.2(information)-302.8(with)]TJ
0 -1.1174 TD
[(us,)-281.9(so)-284.2(that)-282.3(we)-280.7(could)-283.3(follow)-284.2(up)-278.7(with)-282(a)-284.5(direct)-279.9(e-mail)-286.9(or)-284.4(phone)]TJ
0 -1.1116 TD
[(call.)-413.6(Participants)-420(were)-416.5(offered)-413.1(three)-416.9(months)-411(of)-416.9(free)-415.6(mem-)]TJ
T*
[(bership)-285.2(with)-282(IAHPC)-278.8(in)-284.6(exchange)-284.2(for)-279.7(their)-283.4(collaboration.)]TJ
26.5177 38.0832 TD
[(This)-310.8(study)-316.5(was)-310.4(approved)-316.4(by)-307.5(an)-314.4(ethics)-314.3(review)-315.2(board)-311.9(from)]TJ
-1.0137 -1.1174 TD
[(the)-355.9(Fundacio)]TJ
4.9015 .0461 TD
()Tj
.4147 -.0461 TD
[(n)-352.4(Federacio)]TJ
4.3947 .0461 TD
()Tj
.4205 -.0461 TD
.3524 Tc
[(nM)352.4(e)]TJ
1.797 .0461 TD
0 Tc
()Tj
.3859 -.0461 TD
[(dica)-358.2(de)-354.7(Buenos)-354.2(Aires,)-356.5(in)-353.7(Ar-)]TJ
-12.3142 -1.1116 TD
(gentina.)Tj
/F9 1 Tf
8.9663 0 0 8.9663 313.0582 677.4235 Tm
[(Data)-336.2(analysis)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 660.9825 Tm
[(Survey)-330.1(results)-331.3(were)-330.1(exported)-328(to)-330.6(Microsoft)-328.8(Excel)-331.7(and)-327(an-)]TJ
-1.0137 -1.1116 TD
[(alyzed)-327(using)-316.5(IBM)-322(SPSS)-314.8(Statistics.)-322.1(Descriptive)-327.7(analysis)-322(and)]TJ
T*
[(bivariate)-704.9(analysis)-702.2(were)-704.5(conducted)-704.7(using)-696.6(nonparametric)]TJ
0 -1.1174 TD
[(analy)-8(sis)-504.1(as)-510(median)-511.4(and)-511.3(interquartile)-513.7(range)-514.7(and)-505.6(Kruskal)]TJ
0 -1.1116 TD
[(Wallis)-286.7(test)-282.1(for)-279.7(comparing)-284.3(groups.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 313.0582 591.3636 Tm
(Results)Tj
/F9 1 Tf
0 -1.8336 TD
(Prices)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 558.4818 Tm
[(Eighteen)-289.1(countries)-288.7(reported)-287.7(higher)-290.1(dispensing)-288.5(price)-284.4(of)-284.4(IR)]TJ
-1.0137 -1.1116 TD
[(oral)-259.1(and/or)-255.5(injectable)-258.1(morphine)-253.2(than)-253.4(at)-256.9(least)-255.6(one)-252.1(of)-255.6(the)-252.3(other)]TJ
T*
[(opioids)-399.4(with)-397.2(complex)-397.3(delivery)-397.3(formulations)-401.6(\(TD)-397(and)-396.1(SR\).)]TJ
0 -1.1174 TD
[(Table)-302.9(2)-300.6(includes)-299.2(the)-298.3(list)-298.3(of)-295.9(countries)-306(and)-298.2(their)-300.6(income)-298.3(cate-)]TJ
0 -1.1116 TD
[(gory)-430.6(as)-423.6(per)-424.9(the)-425.1(World)-428.3(Bank.)-424.7(Four)-424.7(countries)-427(had)-430.7(multiple)]TJ
T*
[(report)-7.8(s)-311.9(from)-316.6(different)-317.7(locations)-317.7(\(India,)-322.3(Kenya,)-317.4(Mexico,)-318.7(and)]TJ
T*
[(Poland\))-198.9(for)-193.3(a)-192.3(total)-191.4(of)-198(25)-192.3(reports.)-190.7(The)-195.7(Supplementary)-197.7(Table)-193.5(S1)]TJ
0 -1.1174 TD
[(\(Suppl)-6.6(ementary)-566.6(Data)-572.2(available)-567.9(online)-566.7(at)-567.9(www.libertpub.)]TJ
0 -1.1116 TD
[(com/jpm\))-433.1(includes)-437.4(all)-430.9(the)-430.8(prices)-435.1(reported)-431.7(from)-431.8(all)-430.9(the)-430.8(25)]TJ
T*
(locations.)Tj
1.0137 -1.1174 TD
[(Injectable)-298.3(morphine)-287.8(was)-293.1(the)-292.6(highest)-291.2(priced)-291.3(medication)-292.6(in)]TJ
-1.0137 -1.1116 TD
[(seven)-243.8(countries)-248.4(\(Germany,)-241.2(Hungary,)-243.5(Kenya,)-248.3(Mexico,)-243.8(Nepal,)]TJ
T*
[(Poland,)-253.1(and)-246.4(Rwanda\),)-251.5(and)-246.4(the)-246.5(lowest)-250.6(one)-246.4(in)-250(two)-246.2(\(Costa)-250.6(Rica)]TJ
0 -1.1174 TD
[(and)-378.8(Togo\).)-373(The)-380(range)-376.4(in)-376.7(the)-373.2(dispensing)-380.7(price)-376.5(of)-376.6(morphine)]TJ
0 -1.1116 TD
[(injectable)-200.5(for)-193.3(30)-192.3(days)-195.4(of)-192.2(DDD)-196(was)-195.2($74$742)-193.1(\(Costa)-193(Rica)-198(and)]TJ
T*
[(Mexico,)-284.1(respectively\).)]TJ
1.0137 -1.1116 TD
[(SR)-181.6(oral)-184.2(morphine)-184.1(was)-177.9(the)-183.1(most)-184.1(frequently)-180.6(favorably)-185.1(priced)]TJ
-1.0137 -1.1174 TD
[(at)-187.8(the)-183.1(dispensing)-184.8(level.)-184.3(In)-186.5(10)-180.7(countries)-185.1(\(Costa)-187.3(Rica,)-184.1(Germany,)]TJ
0 -1.1116 TD
[(Guate)-8.8(mala,)-201.6(India,)-200.3(Ireland,)-203.6(Nepal,)-208.1(Norway,)-203(Panama,)-204.7(Rwanda,)]TJ
T*
[(and)-246.4(Togo\))-242.8(SR)-239.2(oral)-247.6(morphine)-241.7(was)-241.3(less)-247.2(expensive)-243.7(than)-241.8(IR)-245.1(oral)]TJ
ET
62.022 294.916 490.167 .22678 re
f
62.022 78.123 490.167 .22678 re
f
62.022 266.286 490.167 .22684 re
f
BT
/F7 1 Tf
9.845 0 0 9.845 95.0173 320.5416 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(2.)Tj
/F7 1 Tf
1.2496 0 TD
[(Countries)-340.3(That)-334.4(Reported)-332.2(Higher)-336.2(Dispensing)-336.5(Prices)-334(for)-332.2(Immediate-Release)-336(Morphine)]TJ
-2.2573 -1.0135 TD
[(\(Oral)-333.8(and/or)-335(Injectable\))-334.4(Than)-335.5(Another)-332.4(Opioid)-336.2(Formulation)-336.2(with)-334.7(Complex)-332.2(Delivery)]TJ
9.588 -1.0135 TD
[(Mechanism)-335.4(\(Transdermal)-337(Patch)-334(and/or)-335(SR\))]TJ
/F10 1 Tf
-14.9319 -2.8505 TD
[(Country)-6596.9(Socio)-334.5(economic)-334.9(level)]TJ
21.5485 1.0077 TD
[(Higher)-336.2(price)-335.5(for)-337(IR)-331.4(oral)-338(morphine)]TJ
1.0999 -1.0077 TD
[(\(tablet/capsule)-341.5(and/or)-328.4(liquid\))]TJ
16.1066 1.0077 TD
[(Higher)-336.2(price)-335.5(for)-337(injectable)]TJ
1.3763 -1.0077 TD
[(morphine)-338.1(\(ampoule\))]TJ
/F5 1 Tf
-40.1313 -1.9003 TD
[(Costa)-335.4(Rica)-5420.5(Upper)-335.2(middle)-12418.3(Y)-15279.2(N)]TJ
0 -1.0135 TD
[(El)-337.3(Salvador)-5083.5(Lower)-336.3(middle)-12303.1(NA)-14561.2(Y)]TJ
0 -1.0077 TD
[(Germany)-6149.9(High)-16042.5(Y)-15279.2(Y)]TJ
0 -1.0135 TD
[(Guatemala)-5526.9(Lower)-336.3(middle)-12303.1(Y)-15279.2(Y)]TJ
T*
[(Hungary)-6377.9(High)-16042.5(NA)-14561.2(Y)]TJ
T*
[(India)-7814.9(Upper)-335.2(middle)-12418.3(Y)-15279.2(Y)]TJ
0 -1.0077 TD
[(Ireland)-7034.9(High)-16042.5(Y)-15279.2(Y)]TJ
0 -1.0135 TD
[(Kenya)-7263.9(Lower)-336.3(middle)-12303.1(NA)-14561.2(Y)]TJ
T*
[(Lebanon)-6367.9(Upper)-335.2(middle)-12418.3(NA)-14561.2(Y)]TJ
T*
[(Mexico)-6815.9(Upper)-335.2(middle)-12418.3(N)-15279.2(Y)]TJ
0 -1.0077 TD
[(Nepal)-7482.9(Low)-16209.5(Y)-15279.2(Y)]TJ
0 -1.0135 TD
[(Norway)-6659.9(High)-16042.5(Y)-15279.2(Y)]TJ
T*
[(Panama)-6701.9(Upper)-335.2(middle)-12418.3(Y)-15279.2(Y)]TJ
0 -1.0077 TD
[(Poland)-7095.9(High)-16042.5(NA)-14561.2(Y)]TJ
0 -1.0135 TD
[(Rwanda)-6597.9(Low)-16209.5(Y)-15279.2(Y)]TJ
T*
[(Sweden)-6711.9(High)-16042.5(N)-15279.2(Y)]TJ
T*
[(Togo)-7761.9(Low)-16209.5(Y)-15279.2(N)]TJ
0 -1.0077 TD
[(United)-336.5(Kingdom)-3032.3(High)-16042.5(N)-15279.2(Y)]TJ
6.5633 0 0 5.8334 70.0157 70.1858 Tm
(a)Tj
8.7511 0 0 8.7511 72.9637 66.3307 Tm
[(d)-329.2(one)-334.6(for)-330.5(children)-338.9(\(14)-331.9(years)-330.3(old)]TJ
/F8 1 Tf
13.1252 0 TD
(>)Tj
/F5 1 Tf
.5507 0 TD
[(\).)-330.4(Information)-335.4(contained)-333.9(on)-334.5(this)-328.1(table)-337.4(considered)-330.9(both)-337.4(lists.)]TJ
-14.0127 -1.0236 TD
[(IR,)-331.7(immediate)-334.2(release;)-333.2(N,)-334.2(no;)-332.1(NA,)-335.3(medication)-335.5(not)-332.1(available)-333.8(at)-334.5(the)-333.3(time)-334.9(of)-333.1(the)-333.3(survey;)-332.1(SR,)-333(sustained)-335.9(release;)-333.2(Y,)-334.2(yes.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(1460)Tj
46.9413 0 TD
[(DE)-329.5(LIMA)-336.1(ET)-338.7(AL.)]TJ
ET
endstream
endobj
48 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(morphine)-189.9(\(either)-194.5(solid)-184.1(tablet)-193.6(and/or)-186.4(solution\).)-192.1(In)-186.5(16)-186.5(countries,)]TJ
0 -1.1174 TD
[(SR)-377.4(oral)-380(morphine)-379.9(was)-373.8(less)-379.7(expensive)-382(than)-374.3(injectable)-384.8(mor-)]TJ
0 -1.1116 TD
[(phine)-398.5(\(El)-396.3(Salvador,)-400.4(Germany,)-395.7(Guatemala)-11.2(,)-395.1(Hungary,)-393.3(India,)]TJ
T*
[(Ireland,)-290(Kenya,)-288.6(Lebanon,)-291.1(Mexico,)-289.9(Nepal,)-288.7(Norway,)-289.4(Panama,)]TJ
T*
[(Poland,)-281.9(Rwanda,)-285(Sweden,)-283.8(and)-280.9(United)-285.4(Kingdom\).)]TJ
1.0137 -1.1174 TD
[(TD)-453.5(fentanyl)-460.6(was)-454.4(the)-453.8(second)-458(most)-449.1(frequently)-457(favorably)]TJ
-1.0137 -1.1116 TD
[(priced)-297(at)-291.5(the)-286.8(dispensing)-294.3(level.)-293.7(In)-290.1(six)-291.2(countries)-294.5(\(El)-292.6(Salvador,)]TJ
T*
[(Germany,)-562.7(Hungary,)-560.3(India,)-557.4(Panama,)-556(and)-557.4(Poland\),)-559.4(it)-555.4(was)]TJ
0 -1.1174 TD
[(priced)-366.1(the)-367.5(lowest)-365.8(among)-365(the)-361.7(opioids)-364.9(available)-372.1(in)-359.4(the)-367.5(phar-)]TJ
0 -1.1116 TD
[(macy)-319(the)-315.6(day)-315.5(the)-315.6(study)-316.5(was)-316.2(conducted.)-316.5(In)-313.2(additional)-319.1(10)-313.2(lo-)]TJ
T*
[(cations)-332.6(in)-324.9(7)-323.6(countries)-329.1(\(Guatemala,)-332.5(Ireland,)-330.3(Kenya,)-328.9(Mexico,)]TJ
0 -1.1174 TD
[(Norway,)-220.3(Poland,)-218.5(and)-223.3(Sweden\),)-215.7(TD)-223.1(fentanyl)-218.7(was)-218.3(dispensed)-219.3(at)]TJ
0 -1.1116 TD
[(a)-336.3(lower)-335.9(price)-336.2(than)-339.8(morphine)-333.8(IR)-337.3(solid)-333.9(or)-336.2(liquid)-335.3(and/or)-336.2(mor-)]TJ
T*
[(phine)-283.3(injectable.)]TJ
1.0137 -1.1116 TD
[(In)-192.2(a)-198.1(com)11.6(par)12.8(ati)12.6(ve)-193.4(ana)17.4(lys)14(is)-198(bet)12.7(we)13(en)-193.4(pri)13.9(ces)-189.7(and)-188.8(the)-188.9(cou)12.8(ntr)13.9(ies)12.9()]TJ
-1.0137 -1.1174 TD
[(inc)12.7(ome)-247.6(gro)14(ups)14.2(,)-251.1(the)-246.5(hig)13.9(hes)13(t)-254.7(pri)13.9(ces)-247.3(wer)12(e)-255.7(obs)14.2(erv)12.9(ed)-245.3(in)-250(cou)12.8(ntr)13.9(ies)]TJ
0 -1.1116 TD
[(in)-359.4(the)-350.2(upp)14(er)-360.4(mi)13.7(ddl)13.8(e-i)12.7(nco)12.8(me)-355.9(lev)12.7(el,)-352.5(fol)13.9(low)13(ed)-354.7(by)-359.3(cou)12.8(ntr)13.9(ie)13.8(s)-363.8(i)0(n)]TJ
T*
[(low)13(-in)13.9(com)11.6(e)-198.1(l)0(e)13.8(vel)-188.9(\(Ta)11.7(ble)-183.1(3\).)-189.9(We)-189.9(als)12.9(o)-196.9(c)0(o)13.9(mpa)11.6(red)-188.7(the)-183.1(dis)14(pen)12.8(sin)14(g)]TJ
0 -1.1174 TD
[(pri)13.9(ces)-212.8(of)-215.3(the)-211.9(dif)13.9(fer)12.9(ent)-211.9(opi)13.8(oid)-210.8(med)11.6(ica)11.5(ti)14.8(ons)-216.2(to)-215.4(IR)-216.3(ora)18.6(l)-225.9(m)0(o)13.8(rph)14(ine)]TJ
0 -1.1116 TD
[(tab)12.7(let)-275.4(and)-275.2(dis)14(pla)12.7(yed)-275.2(in)-278.8(a)-284.5(box)-274(plo)19.6(t)-283.5(\(Fi)14(g.)-281(1\).)-276.3(In)-278.6(thi)13.7(s)-283.1(a)0(n)13.9(aly)12.7(sis)14.2(,)-285.7(1)]TJ
T*
[(mea)10.4(ns)-382.1(tha)18.4(t)-387.1(the)-373.2(pri)13.9(ce)-384.7(of)-376.5(the)-379(oth)13.9(er)-377.7(opi)13.8(oid)-372.1(for)14(mul)12.6(ati)12.6(on)-382.3(is)-376.5(the)]TJ
0 -1.1174 TD
[(sam)11.8(e)-180.8(a)0(s)-176(the)-171.6(pri)13.9(ce)-177.3(of)-169.2(IR)-176(ora)12.8(l)-179.8(mor)12.8(phi)13.8(ne)-176.2(tab)18.4(,)]TJ
/F8 1 Tf
16.346 0 TD
(>)Tj
/F5 1 Tf
.5472 0 TD
[(1)-179.6(i)0(s)-174.9(les)12.9(s)-179.5(exp)12.8(ens)13(ive)12.7(,)]TJ
-16.8932 -1.1116 TD
(and)Tj
/F8 1 Tf
1.8431 0 TD
(<)Tj
/F5 1 Tf
.5472 0 TD
[(1)-404.3(i)0(s)-399.6(mor)12.8(e)-405.4(exp)12.8(ens)13(ive)12.7(.)-400.8(W)0(e)-403(fou)14(nd)-399.6(tha)12.7(t)-404.4(the)-390.5(med)11.6(ian)-396.3(dis)14(-)]TJ
-2.3903 -1.1116 TD
[(pen)12.8(sin)14(g)-271.8(pri)13.9(ce)-263.7(for)-262.4(IR)-268.1(ora)12.8(l)-271.9(m)0(o)13.8(rph)14(ine)-263.8(was)-264.3(hi)15(ghe)12.8(r)-271.8(tha)12.7(n)-271.8(the)-258(pri)13.9(ce)]TJ
0 -1.1174 TD
[(for)-556.2(SR)-556(ora)12.8(l)-565.7(m)0(o)13.9(rph)14(ine)-557.5(\(Fi)14(g.)-557.5(1\).)-552.8(SR)-556(hyd)14(rom)12.8(orp)14(hon)14(e)-560.9(was)]TJ
0 -1.1116 TD
[(ava)11.7(ila)12.6(ble)-194.7(onl)13.8(y)-208.4(i)0(n)-198.2(hig)13.9(h-i)13.9(nco)18.6(me)-206.2(co)13.9(unt)13.8(rie)12.7(s,)-200.2(so)-203.6(we)-200.1(wer)12(e)-203.8(una)12.8(ble)-194.7(to)]TJ
T*
[(do)-272.9(com)11.6(pa)13.9(riso)18.7(ns)-272.7(wit)12.8(h)-277.6(c)0(o)13.9(unt)13.8(rie)12.7(s)-277.4(i)0(n)-267.3(oth)13.8(er)-274(inc)12.7(om)13.9(e)-278.7(lev)12.7(els)12.9(.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 59.7543 415.1621 Tm
[(Lists)-336.3(of)-336.6(essential)-334.1(medicines)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 398.7212 Tm
[(From)-281.9(the)-286.8(18)-261.4(co)19.7(un)20.8(tr)15(ie)19.6(s)-271.6(i)0(n)-261.5(S)0(t)20.9(e)0(p)-268.3(A)0(,)-258.8(1)0(2)-267.1(c)0(o)19.7(u)0(n)20.8(t)0(r)20.7(i)0(e)19.6(s)-271.6(we)18.8(re)-268.3(id)20.7(en)19.7(ti)20.6(-)]TJ
-1.0137 -1.1174 TD
[(e)14.1(d)-340.9(e)0(i)19.5(t)0(h)15(e)0(r)-331.6(a)0(s)-337.2(m)0(i)19.5(d)0(d)15.1(l)0(e)-331.8(i)0(n)15(c)0(o)19.7(m)0(e)-332.9(o)0(r)-336.2(l)0(o)20.7(w)-347.5(in)20.7(co)19.7(me)-338.7(an)19.7(d)-346.7(w)0(e)-338.3(l)0(o)20.7(c)0(a)18.5(t)0(e)19.5(d)]TJ
0 -1.1116 TD
[(th)15(ei)19.5(r)-346.6(n)0(a)19.7(t)0(i)20.6(o)0(n)20.8(a)0(l)-337.6(l)0(i)20.6(s)0(t)15.1(s)-346.5(of)-336.2(Es)19.8(se)19.9(nt)20.7(ia)19.6(l)-346.8(M)0(e)18.8(d)0(i)15(c)0(i)19.5(n)0(e)19.7(s)0(:)-336.2([)0(C)19.8(o)0(s)21(t)0(a)-337.6(R)0(i)19.7(c)0(a)12.8(,)]TJ
7.3823 0 0 6.5614 279.4393 381.1464 Tm
(20)Tj
9.843 0 0 9.843 290.1543 376.781 Tm
(El)Tj
-23.4074 -1.1116 TD
[(Sa)14.1(lv)20.7(ad)19.7(or)20.9(,)]TJ
7.3823 0 0 6.5614 96.4346 370.2046 Tm
-.0162 Tc
(21)Tj
9.843 0 0 9.843 106.6393 365.8393 Tm
0 Tc
[(Gu)20(at)19.5(em)18.5(al)19.5(a,)]TJ
7.3823 0 0 6.5614 150.9732 370.2046 Tm
-.0162 Tc
(22)Tj
9.843 0 0 9.843 161.1779 365.8393 Tm
0 Tc
[(In)20.9(di)14.9(a,)]TJ
7.3823 0 0 6.5614 183.3448 370.2046 Tm
(23)Tj
9.843 0 0 9.843 193.5496 365.8393 Tm
[(Ke)13(ny)20.8(a,)]TJ
7.3823 0 0 6.5614 221.159 370.2046 Tm
(24)Tj
9.843 0 0 9.843 231.4204 365.8393 Tm
[(Le)18.5(ba)19.7(no)20.8(n,)]TJ
7.3823 0 0 6.5614 267.6472 370.2046 Tm
-.0162 Tc
(25)Tj
9.843 0 0 9.843 277.8519 365.8393 Tm
0 Tc
[(Me)18.8(x-)]TJ
-22.1576 -1.1174 TD
[(ic)19.6(o,)]TJ
7.3823 0 0 6.5614 73.9275 359.2629 Tm
(26)Tj
9.843 0 0 9.843 82.9984 354.8409 Tm
[(Ne)18.8(pa)19.7(l,)]TJ
7.3823 0 0 6.5614 108.4535 359.2629 Tm
-.0162 Tc
(27)Tj
9.843 0 0 9.843 117.4677 354.8409 Tm
0 Tc
[(Pa)19.8(na)19.7(ma)18.4(,)]TJ
7.3823 0 0 6.5614 150.5196 359.2629 Tm
(28)Tj
9.843 0 0 9.843 159.5905 354.8409 Tm
[(Po)21(la)19.6(nd)20.8(,)]TJ
7.3823 0 0 6.5614 188.7307 359.2629 Tm
-.0162 Tc
(29)Tj
9.843 0 0 9.843 197.7448 354.8409 Tm
0 Tc
[(Rw)18.9(an)19.7(da)19.7(,)]TJ
7.3823 0 0 6.5614 231.8172 359.2629 Tm
(30)Tj
9.843 0 0 9.843 240.8881 354.8409 Tm
[(an)19.7(d)-173.9(T)0(o)19.6(g)0(o)]TJ
7.3823 0 0 6.5614 277.1149 359.2629 Tm
-.0162 Tc
[(31)-16.2(,)11.9(3)-16.2(2)]TJ
9.843 0 0 9.843 293.2157 354.8409 Tm
0 Tc
(].)Tj
-22.7048 -1.1116 TD
[(After)-191.9(an)-187.7(initial)-188.1(review,)-191.9(we)-188.5(found)-189.8(that)-184.4(opioids)-192.1(with)-184.1(complex)]TJ
-1.0137 -1.1116 TD
[(delivery)-224.5(mechanism)-217.4(\(SR)-217.2(and)-217.6(TD\))-218.4(are)-218.7(not)-216.5(included)-218.8(in)-221.2(the)-217.7(lists)]TJ
0 -1.1174 TD
[(of)-255.6(essential)-255.3(medicines)-256.6(of)-255.6(Poland)-249.6(and)-252.1(Rwanda,)-256.2(and)-257.9(thus)-252(were)]TJ
0 -1.1116 TD
[(excluded)-283.1(from)-282(this)-280.9(step.)]TJ
1.0137 -1.1116 TD
[(Table)-446.9(4)-438.8(shows)-449.5(the)-442.3(list)-442.3(of)-439.9(10)-445.7(countries)-444.3(\(Costa)-446.4(Rica,)-443.3(El)]TJ
-1.0137 -1.1116 TD
[(Salvador,)-360.1(Guatemala,)-360.2(India,)-355.8(Kenya,)-352(Lebanon,)-360.3(Mexico,)-353.2(Ne-)]TJ
0 -1.1174 TD
[(pal,)-336.3(Panama,)-342.9(and)-332.8(Togo\))-340.7(that)-334.1(have)-335(opioids)-336.1(with)-339.6(TD)-338.3(and)-332.8(SR)]TJ
0 -1.1116 TD
[(formulations)-568.7(included)-564.3(in)-561(their)-565.6(national)-564.5(lists)-564.2(of)-560.9(essential)]TJ
T*
[(medicines.)-231.2(Nine)-225.4(countries)-225.4(include)-229.2(at)-222.4(least)-226.8(one)-223.3(formulation)-227.9(of)]TJ
0 -1.1174 TD
[(IR)-296.9(morphine)-293.5(\(oral)-294.7(and/or)-295.9(injectable\).)-297.2(In)-295.9(Lebanon,)-291.1(morphine)]TJ
0 -1.1116 TD
[(IR)-331.5(injectable)-333(is)-324.7(included)-328.2(in)-330.6(the)-327.1(EML)-329.1(for)-325.8(anesthesia)-332.3(and)-327(in-)]TJ
T*
[(cludes)-435.1(an)-429.6(SR)-435(oral)-431.9(morphine)-431.8(tablet)-435.5(in)-428.5(formulations)-436.2()50.8(from)]TJ
0 -1.1174 TD
[(10)-169.2(mg)-297.2(to)-296.1(100)-170.3(mg,)49.7()-294.8(but)-302.9(does)-299.1(not)-297.2(specify)-297.9(which)-301.4(formulations)]TJ
25.5097 52.0965 TD
[(in)-267.3(this)-269.4(range)-272.7(are)-270.5(essential.)-270.3(Togo)-270.5(has)-269.2(two)-269.2(essential)-272.6(medicines)]TJ
0 -1.1174 TD
[(lists,)-279.6(one)-280.9(for)-279.7(adults)-284.3(and)-280.9(one)-280.9(for)-279.7(children)-287.8(\()]TJ
/F8 1 Tf
16.8011 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(14)-284.4(years)-278.3(old\).)]TJ
-16.3403 -1.1116 TD
[(The)-247.6(EML)-242.7(for)-250.9(Mexico)-246.1(is)-249.8(developed)-249.7(by)-244.1(the)-246.5(National)-248.5(Health)]TJ
-1.0137 -1.1116 TD
[(Council)-263.6(\(Consejo)-270.1(de)-262.6(Salubridad)-272.6(Nacional\),)-265.6(a)-267.2(national)-265(health)]TJ
T*
[(bo)20.8(dy)-313.2(re)19.7(pr)15.1(es)19.9(en)19.7(ti)20.6(ng)-313.2(th)20.7(e)-330.6(m)15(aj)13.8(or)-313.2(he)19.7(al)19.6(th)-313.4(in)15(st)20.9(it)20.6(ut)20.7(io)20.7(ns)-318.8(an)19.7(d)-323.6(t)0(h)20.7(e)-324.8(Mi)19.8(n-)]TJ
0 -1.1174 TD
[(is)20.9(tr)20.7(y)-387(o)0(f)-376.5(H)0(e)18.8(a)0(l)19.5(t)0(h)20.7(.)-389.3(Th)19.6(e)-382.4(E)0(M)18.7(L)-388.2(\()72.7(C)14.1(ua)19.7(dr)20.9(o)-387(B)0(a)]TJ
15.9198 .0403 TD
()Tj
.3744 -.0403 TD
[(si)20.9(co)19.7()62.3()0(\))-376.5(d)0(i)20.7(s)0(t)15.1(i)0(n)20.7(g)0(u)20.8(i)0(s)20.9(h)0(e)19.7(s)]TJ
-16.2942 -1.1116 TD
[(be)19.7(tw)19.8(ee)18.5(n)-185.4(m)0(e)18.4(d)0(i)20.7(c)0(a)18.5(t)0(i)20.6(o)0(n)15.1(s)-185.2(ne)19.7(ed)19.7(ed)-176.2(fo)20.9(r)-185.4(t)0(h)20.7(e)-186.6(r)21(st)-180.7(le)19.6(ve)19.7(l)-185.5(a)0(n)19.7(d)-185.4(me)18.5(di)20.7(ca)18.5(ti)20.6(on)20.8(s)]TJ
T*
[(ne)19.7(ed)19.7(ed)-320.1(fo)20.9(r)-329.4(s)0(e)19.9(c)0(o)19.7(n)0(d)-319(a)0(n)19.7(d)-329.4(th)20.7(ir)20.7(d)-329.4(l)0(e)19.5(v)0(e)19.7(l)0(s)20.9(.)-331.7(Op)20(io)20.7(id)20.7(s)-329.2(a)0(r)19.7(e)-330.6(in)20.7(cl)19.5(ud)20.8(ed)-320.1(fo)20.9(r)]TJ
0 -1.1174 TD
[(us)21(e)-267.2(i)0(n)-250(t)0(h)20.7(e)-267.2(se)19.9(co)19.7(nd)-255.6(an)19.7(d)-266(t)0(h)20.7(i)0(r)20.7(d)-266(le)19.6(ve)19.7(ls)-255.6(on)20.8(ly)20.7(.)-262.6(T)0(h)19.6(e)-267.2(EM)18.7(L)-261.5(f)0(o)15.1(r)-260.3(Me)18.8(xi)20.7(co)]TJ
0 -1.1116 TD
.013 Tc
[(h)6.1(a)-.8(d)-281.8(t).3(h)6.1(e)-283(mo)6.1(st)-282(nu)6.1(mb)6.1(er)-281.8(of)-281.8(o)6.1(p).4(i)6(o).4(id)-281.8(i)6(n)-281.8(SR)-282.9(an)6.1(d)-281.8(T)-.8(D)-282.7(f).4(o)6.1(r).4(m)4.9(u).4(l)6(a)-.8(ti)6(on)6.1(s)]TJ
T*
.0118 Tc
[(\()5(S)-.7(R)-284.1(m)3.7(or)5(phi)4.8(ne,)-285.4(S)5.1(R)-284.1(o)-.8(x)4.9(y)-.8(codo)4.9(ne,)-285.4(S)5.1(R)-284.1(t)-.9(apentado)4.9(l,)-279.6(an)4.9(d)-283(T)-2(D)-283.9(f)5(en)4.9(-)]TJ
0 -1.1174 TD
.0134 Tc
[(t)6.4(a)-.4(n)6.5(y).8(l)-275.8(p).8(a)5.4(t).7(ch)6.5(es)6.7(\).)]TJ
1.0137 -1.1116 TD
0 Tc
[(The)-190(oldest)-192.2(essential)-197.7(medicines)-193.2(list)-188.9(is)-192.2(from)-189.9(Togo)-195.7(\(2012\))-190.9(and)]TJ
-1.0137 -1.1116 TD
[(the)-338.7(most)-339.6(current)-338.4(ones)-339.4(are)-339.7(from)-339.6(El)-337.6(Salvador,)-342.8(Kenya,)-340.5(Nepal,)]TJ
T*
[(and)-280.9(Mexico)-280.7(\(2016\),)-280.7(and)-280.9(Panama)-287.6(\(2017\).)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 310.8472 546.9164 Tm
[(Procurement)-335.3(process)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 530.4755 Tm
[(Despite)-316.2(different)-323.4(attempts)-317.8(and)-315.5(efforts)-319.7(to)-319.1(nd)-314.2(information)]TJ
-1.0137 -1.1116 TD
[(regarding)-334.8(budget)-330.5(allocation)-337.6(for)-331.5(essential)-335.9(medicines)-337.2(\(in)-331.7(par-)]TJ
T*
[(ticular)-229.3(for)-227.9(opioids\),)-225.4(and)-229.1(information)-227.9(on)-226.8(how)-228.8(the)-223.5(procurement)]TJ
0 -1.1174 TD
[(process)-407(for)-406.4(medicines)-412.1(is)-405.3(nanced)-408.5(in)-405.5(the)-407.8(public)-411.2(sector,)-409.7(we)]TJ
0 -1.1116 TD
[(were)-255.2(not)-251.1(successful.)-259.4(We)-259.1(were)-255.2(also)-253.2(unsuccessful)-258.1(in)-255.7(our)-250.9(effort)]TJ
T*
[(to)-514.9(contact)-518.3(directly)-518.3(the)-517.2(corresponding)-523.4(Ministry)-516.7(of)-514.8(Health)]TJ
0 -1.1174 TD
[(representative)-286.3(who)-280.6(could)-283.3(provide)-279.7(this)-280.9(information.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 310.8472 439.9369 Tm
[(Conrmation)-332.9(process)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 423.4959 Tm
[(Eleven)-309.8(participants)-316.5(in)-313.3(previous)-309.4(OPW)-311.5(responded)-317.3(and)-309.7(ver-)]TJ
-1.0137 -1.1116 TD
[(ied/conrmed)-520(the)-523(country)-521.6(information)-521.7(with)-518.2(their)-519.5(corre-)]TJ
0 -1.1174 TD
[(sponding)-544.4(Minist)-7.7(ry)-543.6(of)-549.3(Health.)-549.2(They)-548.2(also)-552.7(conrmed)-547.8(their)]TJ
0 -1.1116 TD
[(voluntary)-495.1(participation.)-499.9(Participants)-494.9(are)-500.9(listed)-491.8(in)-497.7(the)-494.2(Ac-)]TJ
T*
[(knowledgments)-283.8(section.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 354.8409 Tm
(Discussion)Tj
/F9 1 Tf
0 -1.8336 TD
(Prices)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 321.959 Tm
[(The)-230.3(analysis)-229.9(of)-232.6(prices)-233.5(was)-229.8(based)-232.3(on)-232.6(the)-229.2(results)-233.3(of)-232.5(previous)]TJ
-1.0137 -1.1116 TD
[(ndings)-209.1(of)-209.5(the)-206.2(OPW.)-211.3(All)-211.8(the)-206.2(OPW)-213.6(reports)-210.3(were)-209.2(from)-207.2(large)-215.3(or)]TJ
T*
[(medium)-327.1(urban)-323.4(centers.)-331.3(This)-328.1(is)-324.7(not)-326(surprising)-327.6(given)-323.6(that)-328.4(the)]TJ
T*
[(prices)-268(we)-269.2(requested)-272.5(were)-272.5(for)-268.2(pharmacies)-270.2(close)-272.7(to)-267.3(or)-267.1(inside)-272.8(a)]TJ
0 -1.1174 TD
[(health)-205(facility)-201.7(that)-207.4(provides)-200(diagnostic)-209.4(and)-200.3(treatment)-210.8(services)]TJ
0 -1.1116 TD
[(for)-245.1(patients)-247.5(with)-247.4(life-threatening)-247.5(conditions)-248.5(such)-247.3(as)-245.1(HIV)-246.9(and)]TJ
T*
[(cancer,)-412.1(and)-413.4(that)-409(these)-410.9(major)-416.9(treatment)-412.4(centers)-414.3(are)-408.8(usually)]TJ
0 -1.1174 TD
[(located)-282.2(in)-278.8(large)-284.4(urban)-283.1(areas.)]TJ
1.0137 -1.1116 TD
[(Our)-326.7(previous)-326.7(OPW)-328.8(studies)-325.5(and)-327(this)-327(one)-327(as)-331.5(well,)-326.9(indicate)]TJ
-1.0137 -1.1116 TD
[(that)-259.3(despite)-263.5(having)-261.3(a)-255.7(lower)-261.1(price)-261.4(in)-261.5(the)-258(internation)-9.2(al)-256.9(market,)]TJ
0 -1.1174 TD
[(generic)-339.6(IR)-343(oral)-339.7(morphine)-339.6(tends)-346.4(to)-336.4(be)-343.2(dispensed)-340.3(at)-343.3(a)-336.3(higher)]TJ
ET
59.754 172.63 490.167 .28348 re
f
59.754 77.442 490.167 .28348 re
f
59.754 143.83 490.167 .22676 re
f
59.754 126.142 490.167 .22675 re
f
BT
/F7 1 Tf
9.845 0 0 9.845 128.6362 188.2771 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(3.)Tj
/F7 1 Tf
1.2496 0 TD
[(Mean)-334(Rank)-334(of)-337(Dispensing)-336.5(Prices)-334(for)]TJ
/F5 1 Tf
16.9359 0 TD
(30)Tj
/F7 1 Tf
1.002 0 TD
[(-Day)-332.7(Treatment)-334.5(of)-337(Different)]TJ
-18.22 -1.0077 TD
[(Opioid)-336.2(Formulations)-337(Categorized)-333.7(by)-330(Income)-336.2(Country)-338.2(Group)]TJ
/F10 1 Tf
-4.4168 -1.8427 TD
[(IR)-337.2(oral)-332.2(morphine)]TJ
.7371 -1.0135 TD
(tablet/capsule)Tj
7.1809 1.0135 TD
[(IR)-337.2(oral)-332.2(morphine)]TJ
1.9464 -1.0135 TD
(solution)Tj
6.1904 1.0135 TD
(Injectable)Tj
.0921 -1.0135 TD
(morphine)Tj
5.6146 1.0135 TD
[(SR)-331.4(oral)]TJ
-.357 -1.0135 TD
(morphine)Tj
6.225 1.0135 TD
(TDP)Tj
-.6737 -1.0135 TD
(fentanyl)Tj
5.3151 1.0135 TD
[(SR)-331.4(oral)]TJ
-.5874 -1.0135 TD
(oxycodone)Tj
6.8066 1.0135 TD
[(SR)-337.2(oral)]TJ
-1.6354 -1.0135 TD
(hydromorphone)Tj
-43.4022 -1.8139 TD
[(Income)-337.3(level)-2698.1(Mean)-334.4(rank)-3471.6(Mean)-334.4(rank)-2141.4(Mean)-334.4(rank)-805.4(Mean)-334.4(rank)-811.2(Mean)-334.4(rank)-805.4(Mean)-334.4(rank)-1778.6(Mean)-334.4(rank)]TJ
/F5 1 Tf
0 -1.9003 TD
[(High)-339(income)-3936.9(6.25)-6421.4(5.8)-5084.4(9.11)-4129.5(9)-4129.9(7.33)-3501.8(4.75)-4722.6(2.5)]TJ
0 -1.0135 TD
[(Upper)-335.2(middle)-3982(10)-6797.1(8.5)-5084.4(18.2)-3507.5(15.5)-3501.8(18.2)-3876.1(11)-5006.2(NA)]TJ
0 -1.0077 TD
[(Lower)-336.3(middle)-3740.2(4.5)-6673.7(3.5)-4836.8(13.88)-3001.8(12.25)-3629.5(12)-3629.9(12.67)-4378.1(NA)]TJ
0 -1.0135 TD
[(Low)-339(income)-4725.9(9)-7423.8(2)-5212.5(13.67)-3629.5(10)-4251.8(23)-4033(NA)-4789(NA)]TJ
6.5633 0 0 5.8334 67.748 69.5622 Tm
(a)Tj
8.7511 0 0 8.7511 70.696 65.6504 Tm
[(\(4)-333.1(years)-330.3(old)]TJ
/F8 1 Tf
4.8912 0 TD
(>)Tj
/F5 1 Tf
.5507 0 TD
[(\).)-336.9(Information)-328.9(contained)-333.9(on)-334.5(this)-334.6(table)-330.9(considered)-337.4(both)-331(lists.)]TJ
-5.7787 -1.0236 TD
[(TDP,)-334.3(transdermal)-331.1(patch;)-336.2(NA,)-335.3(not)-332.1(available.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(OPIOID)-336.3(PRICE)-333.8(WATCH)-338(PROJECT)]TJ
52.4612 0 TD
(1461)Tj
ET
endstream
endobj
52 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 62.022 385.3416 Tm
0 0 0 rg
0 Tc
0 Tw
[(price)-221(than)-213(formulations)-223.1(that)-213.2(are)-218.7(more)-219.9(expensive,)-218.4(in)-215.4(particular)]TJ
0 -1.1116 TD
[(SR)-279.5(oral)-282.1(morphine)-282(and)-280.9(TD)-286.5(fentanyl)-282.1(patch.)]TJ
1.0137 -1.1116 TD
[(Injectable)-338.6(morphine)-333.9(was)-333.4(one)-332.8(of)-330.5(the)-332.9(highest)-331.5(priced)-337.3(medi-)]TJ
-1.0137 -1.1116 TD
[(cations)-396(and)-396.1(we)-395.9(are)-397.3(unable)-400.7(to)-394(determine)-395(the)-396.3(reason)-400.4(behind)]TJ
0 -1.1174 TD
[(such)-356.7(a)-353.6(large)-359.3(overhead)-352.1(betwe)-8.8(en)-354.7(the)-350.2(reported)-356.8(purchase)-357.7(price)]TJ
0 -1.1116 TD
[(and)-401.9(the)-402(selling)-400.7(price.)-403(Ampoules)-403.7(contain)-402(generic)-403(morphine)]TJ
T*
[(and)-280.9(thus)-280.8(should)-283(not)-279.9(be)-279.8(priced)-285.5(at)-280(such)-281.8(high)-281(levels.)]TJ
1.0137 -1.1174 TD
[(Results)-194.1(also)-189.8(show)-189.4(that)-190.1(for)-193.3(six)-187.5(formulations,)-192(countries)-196.6(in)-186.6(the)]TJ
-1.0137 -1.1116 TD
[(upper)-363.7(middle-income)-366.2(category)-363.7(had)-361.6(the)-361.7(highest)-360.3(prices)-365.9(for)-360.3(a)]TJ
T*
[(30-day)-353.3(treatment)-360.6(among)-353.5(the)-355.9(gross)-356.4(national)-357.1(income)-355.9(groups.)]TJ
0 -1.1174 TD
[(Sadly,)-407.5(in)-405.5(many)-410(of)-405.3(these)-410.9(countries,)-407.4(the)-407.8(ability)-406.8(to)-405.5(negotiate)]TJ
0 -1.1116 TD
[(lower)-226.5(prices)-233.5(at)-222.4(the)-229.2(international)-231.5(level)-227(and)-229.1(the)-223.5(funding)-226.7(pool)-229.2(to)]TJ
T*
[(share)-612.4(healthcare)-616.1(expenditures)-615.8(is)-606.9(still)-616.4(inadequate)-614.9(or)-606.9(not)]TJ
T*
[(available,)-346.7(and)-344.3(thus)-344.2(these)-341.8(higher)-347.7(costs)-346.2(are)-339.7(transferred)-349.5(to)-342.1(the)]TJ
0 -1.1174 TD
[(patients)-282(who)-280.6(must)-282(pay)-280.9(out)-279.9(of)-284.4(pocket.)]TJ
1.0137 -1.1116 TD
[(The)-207.3(fact)-208.4(that)-207.4(this)-206.1(study)-207(and)-206.1(the)-206.2(previous)-211.5(OPW)-207.9(studies)-204.6(have)]TJ
-1.0137 -1.1116 TD
[(shown)-369(favorable)-376.3(pricing)-366.2(for)-371.9(medications)-374.1(that)-368.7(are)-368.5(more)-369.6(ex-)]TJ
0 -1.1174 TD
[(pensive)-332.5(in)-330.6(the)-332.9(international)-335.2(suppliers)-334.5(market)-332.8(indicates)-330.4(that)]TJ
0 -1.1116 TD
[(there)-393.8(is)-388(little)-394.3(interest)-391.4(and)-390.4(limited)-396.5(political)-393(will)-391.6(to)-388.2(improve)]TJ
T*
[(availability)-317(and)-309.7(access)-316.1(to)-307.6(IR)-314.2(generic)-310.8(morphine,)-314.2(both)-309.8(in)-307.6(oral)]TJ
0 -1.1174 TD
[(and)-390.4(injectable)-396.3(formulations.)-393.6(We)-385.8(are)-391.5(unable)-395(to)-388.2(identify)-390.5(the)]TJ
0 -1.1116 TD
[(reasons)-332.2(behind)-324.7(this,)-330.4(which)-330.2(is)-324.7(common)-327(across)-331.1(several)-327.9(coun-)]TJ
T*
[(tries)-248.6(in)-244.2(all)-246.6(income)-252.2(levels.)-248.6(Options)-244.8(could)-248.7(be)-245.3(that)-247.7(the)-246.5(countries)]TJ
0 -1.1174 TD
[(in)-474.6(lower)-474.2(income)-476.8(levels)-475.5(may)-472.2(have)-473.3(less)-471.8(negotiating)-475.7(power)]TJ
0 -1.1116 TD
[(when)-242.6(buying)-237.1(in)-244.2(the)-235(internation)-9.2(al)-239.6(markets,)-239.2(lack)-243(of)-238.3(knowledge)]TJ
T*
[(about)-329.3(less)-333.6(expensive)-330.1(vendors)-331.2(of)-330.5(morphine)-328.1(tablets)-332.8(in)-330.6(the)-327.1(in-)]TJ
T*
[(ternational)-419.3(market,)-411.1(and/or)-411(may)-414.6(fall)-414.7(under)-409.8(the)-413.5(inuence)-415.5(of)]TJ
0 -1.1174 TD
[(groups)-363.5(and)-355.8(individuals)-364.9(who)-361.3(have)-363.8(a)-359.4(vested)-360.2(interest)-362.6(in)-359.4(more)]TJ
0 -1.1116 TD
.0122 Tc
[(ex)5.3(pensi)5.2(v)-.4(e)-341.4(o)5.3(pi)5.2(oi)5.2(ds)-340(ov)5.3(er)-340.2(I)5.4(R)-341.3(generi)5.2(c)-341.4(m)-1.6(o)5.3(r)-.4(p)5.3(h)-.4(in)5.3(e.)-336.8(A)-341.1(r)-.4(ecent)-340.4(r)5.4(e-)]TJ
T*
.012 Tc
[(po)5.1(rt)-311.8(pu)5.1(bl)5(ish)5.1(e)-1.8(d)-311.6(b)5.1(y)-311.6(a)-312.8(Lancet)-311.8(Co)5.1(mmis)5.3(sio)5.1(n)-311.6(on)-311.6(Glob)5.1(al)-311.8(Access)]TJ
0 -1.1174 TD
[(to)-213.7(Palli)5(at)5(ive)-214.9(C)-1.6(are)-214.9(a)-1.8(n)5.1(d)-219.5(Pain)-213.7(Relie)]TJ
13.2128 0 TD
.0118 Tc
[(f)-219.7(s)5.1(tresses)-219.5(t)4.8(he)-220.8(i)4.8(m)-2(p)4.9(o)-.8(r)5(t)-.9(ance)-215.1(of)]TJ
12.2912 33.4005 TD
[(impro)4.9(vi)4.8(ng)-190.9(access)-190.7(t)4.8(o)-190.9(generic)-186.3(m)-2(o)4.9(rph)4.9(in)4.9(e)-192(i)-.9(n)-190.9(b)4.9(ot)4.8(h)-190.9(i)-.9(n)4.9(j)-.9(ectabl)4.8(e)-192(a)-2(n)4.9(d)]TJ
0 -1.1116 TD
.012 Tc
[(oral)-478.8(f)-.6(o)5.1(r)-.6(mulati)5(on)5.1(s,)-475.2(par)5.2(t)-.7(i)5(c)-1.8(ul)5(ar)5.2(ly)-478.7(i)5(n)-478.7(co)5.1(un)5.1(tri)5(e)-1.8(s)-478.5(w)4.3(it)5(h)-478.7(l)-.7(ess)-478.5(r)-.6(e-)]TJ
T*
[(sou)5(r)-.7(ces.)]TJ
7.3823 0 0 6.5614 345.8834 367.8235 Tm
.0145 Tc
(33)Tj
9.843 0 0 9.843 357.3353 363.4582 Tm
.012 Tc
[(Gov)5.1(e)-1.8(rn)5.1(ment)5(s)-392.1(t)5(hat)-392.4(h)5.1(ave)-387.7(n)5.1(ot)-386.6(don)5.1(e)-387.7(s)-.4(o)-392.3(s)5.3(ho)5.1(uld)-386.5(i)-.7(n)5.1(-)]TJ
-4.4983 -1.1116 TD
.0118 Tc
[(clu)4.9(d)-.8(e)-405.2(I)5(R)-405(g)-.8(eneric)-399.4(mo)4.9(rph)4.9(in)4.9(e)-405.2(f)-.8(o)4.9(r)-.8(mulati)4.8(on)4.9(s)-403.8(i)-.9(n)-404(t)-1(h)4.9(e)-2(i)4.8(r)-404(nati)4.8(onal)]TJ
0 -1.1174 TD
.012 Tc
[(healt)5(h)-403.8(pro)5.1(gr)5.2(ams)-409.4(t)5(o)-403.8(m)-1.8(axi)5(m)-1.8(i)5(z)-1.8(e)-405(t)-.7(h)5.1(e)-405(use)-405(o)5.1(f)-403.8(r)-.6(es)5.3(ou)5.1(rces)-403.6(in)-403.8(th)5.1(e)]TJ
0 -1.1116 TD
.0123 Tc
[(pro)5.4(cu)5.4(remen)5.4(t)-276.9(of)-276.8(medi)5.3(ci)5.3(nes.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 313.0582 303.1369 Tm
0 Tc
[(Lists)-336.3(of)-336.6(essential)-334.1(medicines)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 286.696 Tm
[(The)-403.1(WHO)-404.7(updates)-407.4(its)-400.8(model)-405.5(list)-402(of)-399.6(essential)-410.8(medicines)]TJ
-1.0137 -1.1116 TD
[(every)-197.9(two)-188.6(years)-197.7(and)-188.8(the)-194.7(decisions)-196.4(are)-189.9(taken)-192.3(by)-192.3(a)-192.3(committee)-194.8(of)]TJ
T*
[(experts,)-451.1(based)-439.6(on)-445.7(analysis)-443(of)-445.7(scientic)-445.4(evidence)-445.6(and)-448(cost)]TJ
0 -1.1174 TD
[(effectiveness)-388.6(through)-382.2(an)-377.7(open)-380(transparent)-384.2(process.)-381.7(The)-380(in-)]TJ
0 -1.1116 TD
[(clusio)-7.8(n)-289.1(o)0(f)-290.2(medications)-293.5(in)-290.3(a)-290.2(national)-293.8(EML)-294.6(should)-288.8(also)-293.5(fulll)]TJ
T*
[(the)-425.1(criteria)-433.1(of)-422.6(efcacy,)-430.3(safety,)-427(and)-419.2(cost-e)-8.8(ffectiveness,)-430(and)]TJ
0 -1.1174 TD
[(indicate)-306.4(the)-298.3(political)-300.9(will)-293.7(to)-301.8(ensure)-296.7(their)-300.6(availability)-299.7(and)-298.2(af-)]TJ
0 -1.1116 TD
[(fordability)-198(of)-186.5(such)-195.4(medicines,)-190.9(especially)-194.4(to)-192.4(those)-190.9(living)-191.3(under)]TJ
T*
[(the)-286.8(poverty)-279.7(line.)]TJ
1.0137 -1.1174 TD
[(Of)-302.5(the)-298.3(list)-298.3(of)-301.7(12)-295.9(countries)-306(included)-299.4(in)-296.1(the)-304.1(essential)-301.4(medi-)]TJ
-1.0137 -1.1116 TD
[(cines)-186.3(analysis,)-187.2(the)-183.1(lists)-184.1(of)-180.7(El)-182.1(Salvador)-183.9(Guatemala)-184(and)-183(Panama)]TJ
T*
[(were)-312.8(the)-304.1(rst)-309.4(editions.)-307.4(Two)-304.9(countries)-311.8(\(Poland)-308.3(and)-304(Rwanda\))]TJ
T*
[(did)-423.9(not)-418.1(include)-425(expensive)-422.3(formulations)-424.7(in)-417(their)-421.6(list)-425.1(of)-416.9(es-)]TJ
0 -1.1174 TD
[(sential)-361.6(medicines,)-358(thus)-355.7(ensuring)-355.5(that)-351.4(government)-360.3(funds)-356.6(are)]TJ
0 -1.1116 TD
[(used)-414.3(to)-411.3(buy)-406.5(the)-413.5(least)-411.1(expensive)-416.5(medications)-414.5(and)-407.6(formula-)]TJ
T*
[(tions,)-297(leading)-292.5(to)-296.1(greater)-299.2(cost-effectiveness.)-300.7(All)-292.4(countries)-294.5(in-)]TJ
0 -1.1174 TD
[(clude)-365.1(at)-354.8(least)-359.2(one)-361.6(formulation)-360.4(of)-359.3(IR)-354.5(morphine)-362.6(\(oral)-358.1(and/or)]TJ
0 -1.1116 TD
[(injectable\).)-377.8(Nepal)-377.5(and)-373.1(El)-372.2(Salvador)-373.9(had)-373.1(a)-370.9(very)-374.2(detailed)-369.8(de-)]TJ
T*
[(scription)-333.8(of)-330.5(the)-327.1(methodolog)-7.9(y)-323.6(a)0(s)-331.5(well)-335(as)-325.7(the)-332.9(names)-331.4(of)-330.5(those)]TJ
0 -1.1174 TD
[(who)-303.7(took)-304(part)-305.2(in)-301.8(the)-304.1(process)-303.4(to)-301.8(revise)-302.6(and)-304(update)-308.6(the)-298.3(list)-304.1(of)]TJ
0 -1.1116 TD
[(essential)-382(medicines.)-381(The)-380(essential)-382(medicines)-377.6(lists)-379.9(for)-377.6(Gua-)]TJ
T*
[(temala)-512.7(and)-505.6(Lebanon)-506.6(state)-509(that)-501.2(the)-505.7(selection)-508.9(is)-509(based)-503(on)]TJ
ET
q
360.926 0 0 287.32 126.822 444.926 cm
/Im1 Do
Q
BT
/F6 1 Tf
9.845 0 0 9.845 62.022 428.1448 Tm
[(FIG.)-290.7(1.)]TJ
/F5 1 Tf
4.0713 0 TD
[(Bo)20.1(x)-283.2(p)0(l)20.9(o)0(t)-267(o)0(f)-272.6(t)0(h)20.9(e)-278.6(di)15.1(sp)21.2(en)19.9(si)21(ng)-272.6(pr)21(ic)19.7(e)-278.6(o)0(f)-272.6(s)0(e)20.1(l)0(e)19.7(c)0(t)19.7(e)0(d)-273.8(o)0(p)21.1(i)0(o)20.9(i)0(d)20.9(s)-283(co)19.9(mp)19.9(ar)19.9(ed)-273.8(to)-267.1(th)20.9(e)-284.3(p)0(r)21.1(i)0(c)19.7(e)-278.6(of)-272.6(IR)-267.9(or)15.3(al)-268.2(mo)19.9(rp)21(hi)20.9(ne)-273.8(\(g)21(ol)20.9(d)-283.2(s)0(t)21(a)0(n)19.9(d)0(a)19.9(r)0(d)21(\))0(.)-275(I)0(R)20.1(,)]TJ
-4.0713 -1.0135 TD
[(im)19.7(me)18.7(di)20.9(at)19.7(e)-324.6(r)0(e)19.9(l)0(e)19.7(a)0(s)14.3(e)0(.)-310.7(\()]TJ
7.3837 0 0 6.5625 141.8456 422.5322 Tm
(o)Tj
9.845 0 0 9.845 145.474 418.1668 Tm
[(at)19.7(yp)21.1(ic)19.7(al)-314.3(va)19.9(lu)20.9(es)14.3(;)-323.6(*)0(e)19.9(x)0(t)20.9(r)0(e)19.9(m)0(e)-315.3(v)0(a)19.9(l)0(u)20.9(e)0(s)20.1(.)0(\))]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(1462)Tj
46.9413 0 TD
[(DE)-329.5(LIMA)-336.1(ET)-338.7(AL.)]TJ
ET
endstream
endobj
54 0 obj
<>stream
Adobe d C
W
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? Nl~Lf,Ṟ"kUbĐ-}? 4X " 4X " 4X " 4X " 4X " 9 4X " 4X " 4X " 4X " 4X " 4X " 9 4X " 4X " 4X " 4X " 9 4X " 4X " 4X " 4X " 9 4X " 9 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 9 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 9 4X " 9 4X " 4X " 4X " 9 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 9 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " 4X " I 04m7oY6S`
ֹg> e M GM6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6sw 'oy ':lߐ, 鳠͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfy ?y zZEyq]rk kSʔ[o;kuӘvaP'4s~VisyE4ײF*2yf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳk;| l8oqZ.ZT
ispgxzAhp3M.ƥOx7ӕ@
_M@3͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfy ?C͜ % 17 6tٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l5Z U\y~C &